<i>ESR1</i> NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of <i>ESR1</i> Mutations in Liquid Biopsies
A considerable number of estrogen receptor-positive breast cancer (ER<sup>+ </sup>BrCa) patients develop resistance to endocrine treatment. One of the most important resistance mechanisms is the presence of <i>ESR1</i> mutations. We developed and analytically validated a high...
Main Authors: | Dimitra Stergiopoulou, Athina Markou, Eleni Tzanikou, Ioannis Ladas, G. Mike Makrigiorgos, Vassilis Georgoulias, Evi Lianidou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/556 |
Similar Items
-
<i>PIM-1</i> Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients
by: Athina Markou, et al.
Published: (2020-05-01) -
Differential <i>ESR1</i> Promoter Methylation in the Peripheral Blood—Findings from the Women 40+ Healthy Aging Study
by: Elena S. Gardini, et al.
Published: (2020-05-01) -
Currently Applied Molecular Assays for Identifying <i>ESR1</i> Mutations in Patients with Advanced Breast Cancer
by: Nuri Lee, et al.
Published: (2020-11-01) -
Altered Expression of <i>ESR1</i>, <i>ESR2</i>, <i>PELP1</i> and <i>c-SRC</i> Genes Is Associated with Ovarian Cancer Manifestation
by: Monika Englert-Golon, et al.
Published: (2021-06-01) -
ESR1 and ESR2 gene markers are not associated with number of piglets born alive in Italian Large White sows
by: Vincenzo Russo, et al.
Published: (2011-07-01)